Brought to you by:
NESVS 2023: Novel IVC filter retrieval device slashes procedural time and radiation exposure during in vivo experiments, Yale researchers report
An inferior vena cava (IVC) filter retrieval device dubbed the next-generation in removal of the venous thromboembolism-fighting tools could substantially cut procedural times and radiation exposure, according to data emerging out of in vivo testing at Yale University. The Articulating…
New clinical data support AI solution for improved PE detection and care coordination
Viz.ai has announced new clinical data supporting advancements in pulmonary embolism (PE) detection. Two studies have demonstrated the real-world clinical efficacy of Viz.ai’s PE module to quickly and accurately identify PE and associated right heart strain, accelerate care coordination, and improve healthcare…
‘Vascular surgery should be a key member of pulmonary embolism response teams’
“PERT care is the coalition of the willing,” quipped Dennis Gable, MD, a vascular surgeon at Texas Vascular Associates in Plano, Texas. He was referring to team-based care for pulmonary embolism (PE) patients and how, unlike acute stroke intervention and…
The essential ‘need’ for vascular surgeons in pulmonary embolism treatment paradigm
The specter of pulmonary embolism (PE) as a common and lethal disease process—with mortality of massive PE static at about 50% for decades while rapid advances were made in stroke and STEMI care—forms the backdrop to a VAM 2023 breakfast…
FLAME, FLASH and ongoing PEERLESS trials collect ‘compelling’ data for FlowTriever device
Speaking on the FLAME, FLASH and PEERLESS trials that each collected data on the FlowTriever (Inari Medical) device for the treatment of pulmonary embolism (PE), Ripal Gandhi, MD, Miami Cardiac & Vascular Institute & Miami Cancer Institute, Miami, elaborated on…
The top 10 most popular Vascular Specialist stories of February 2023
In February 2023, the hits with Vascular Specialist readers included positive safety and efficacy findings from the PRESERVE trial; the announcement of the scientific program for Sudan’s first vascular meeting; the release of a former Society for Vascular Surgery (SVS) President’s…
AVF 2023: FLASH registry suggests ‘favorable safety and effectiveness profile’ in high-risk PE patients
Among 61 high-risk pulmonary embolism (PE) patients followed through to the 30-day visit in the U.S. cohort of the FLASH registry, no mortalities were recorded, while at 48 hours post-treatment with the FlowTriever mechanical embolectomy system, likewise, there were no…
New study demonstrates IVC filters ‘safe and effective’ in treating venous thromboembolism
Few adverse events are connected to the use of inferior vena cava (IVC) filters to help prevent deep vein blood clots from developing into pulmonary embolisms (PE), according to the findings of the Predicting the safety and effectiveness of inferior…
Viz.ai launches AI-powered Viz Vascular Suite
Viz.ai has announced the launch of Viz Vascular Suite—artificial intelligence (AI)-powered software enabling vascular care teams to automatically detect and triage care for suspected pulmonary embolism, right heart strain, aortic dissection, and abdominal aortic aneurysm (AAA). The company submitted a new 510(k)…
Penumbra launches Lightning Flash mechanical thrombectomy system
Penumbra have announced the Food and Drug Administration (FDA) clearance and launch of its Lightning Flash mechanical thrombectomy system. “Lightning Flash features Penumbra’s novel Lightning intelligent aspiration technology, now with dual clot detection algorithms,” the company notes in a press release,…